Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-28

Clinical Trial Update: Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating induction of puberty in girls with Turner syndrome using 17-beta estradiol has completed, per the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Turner Syndrome | Phase 3 | Status: COMPLETED